151 related articles for article (PubMed ID: 31797856)
21. Alpha-L-fucosidase levels in patients with oral submucous fibrosis and controls: A comparative study.
Suresh H; Gunasekaran N; James A; Krishnan R; Thayalan DK; Kumar AR
J Oral Maxillofac Pathol; 2022; 26(4):594. PubMed ID: 37082061
[TBL] [Abstract][Full Text] [Related]
22. Patterns of Tobacco Use and its Relation to Oral Precancers and Cancers among Individuals Visiting a Tertiary Hospital in South India.
Khan A; Ongole R; Baptist J; Srikant N; Lukmani F
J Contemp Dent Pract; 2020 Mar; 21(3):304-309. PubMed ID: 32434979
[TBL] [Abstract][Full Text] [Related]
23. Salivary pooling: is it specific to particular regions in oral submucous fibrosis?
Arakeri G; Colbert S; Patil SG; Hale B; Merkx MA; Brennan PA
Br J Oral Maxillofac Surg; 2015 Mar; 53(3):275-8. PubMed ID: 25592220
[TBL] [Abstract][Full Text] [Related]
24. Expression of salivary levels of S100A7 in oral submucous fibrosis and oral leukoplakia.
Fathima R; Ramamoorthi R; Gopalakrishnan S; Jayaseelan VP; Muniapillai S
J Oral Maxillofac Pathol; 2024; 28(1):84-89. PubMed ID: 38800445
[TBL] [Abstract][Full Text] [Related]
25. Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.
Singh P; Srivastava AN; Sharma R; Mateen S; Shukla B; Singh A; Chandel S
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1053-1057. PubMed ID: 29699056
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Gustatory Function in Oral Submucous Fibrosis Patients and Gutka Chewers.
Bangi BB; Ginjupally U; Nadendla LK; Mekala MR; B JL; Kakumani A
Asian Pac J Cancer Prev; 2019 Feb; 20(2):569-573. PubMed ID: 30803222
[TBL] [Abstract][Full Text] [Related]
27. Estimation of salivary lactate dehydrogenase in oral leukoplakia and oral squamous cell carcinoma: a biochemical study.
Patel S; Metgud R
J Cancer Res Ther; 2015; 11(1):119-23. PubMed ID: 25879348
[TBL] [Abstract][Full Text] [Related]
28. Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma.
Punyani SR; Sathawane RS
Clin Oral Investig; 2013 Mar; 17(2):517-24. PubMed ID: 22526890
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Salivary Flow Rate and pH Among Areca Nut Chewers and Oral Submucous Fibrosis Subjects: A Comparative Study.
Abdul Khader NF; Dyasanoor S
J Cancer Prev; 2015 Sep; 20(3):208-15. PubMed ID: 26473160
[TBL] [Abstract][Full Text] [Related]
30. Comparative Evaluation of Plasma Fibrinogen Degradation Product and Salivary Fibrin Precipitating Factor in Oral Submucous Fibrosis Patients and Betel Quid Chewers.
Megha B; Anekar J; Raj AC; Deepika N; Kumar KS
Contemp Clin Dent; 2023; 14(4):289-292. PubMed ID: 38344155
[TBL] [Abstract][Full Text] [Related]
31. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Therapeutic Efficacy of Different Treatment Modalities in Oral Submucous Fibrosis: A Comparative Study.
Tp B; T AG; Varghese M; Raghavan R; Vm MN; Pius A
J Contemp Dent Pract; 2019 Mar; 20(3):390-394. PubMed ID: 31204333
[TBL] [Abstract][Full Text] [Related]
33. Effect of α-tocopherol on salivary reactive oxygen species and trace elements in oral submucous fibrosis.
Chitra S; Balasubramaniam M; Hazra J
Ann Clin Biochem; 2012 May; 49(Pt 3):262-5. PubMed ID: 22337705
[TBL] [Abstract][Full Text] [Related]
34. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.
Kaur J; Politis C; Jacobs R
Clin Oral Investig; 2016 Mar; 20(2):315-9. PubMed ID: 26077895
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Salivary Opiorphin, pH and Flow Rate in Oral Submucous Fibrosis - A Case - Control Observational Study.
Varsha KS; Lakshmi KC; Ganesan A; Kannan A; Aniyan KY
J Pharm Bioallied Sci; 2023 Jul; 15(Suppl 1):S656-S660. PubMed ID: 37654371
[TBL] [Abstract][Full Text] [Related]
36. Habit-associated salivary pH changes in oral submucous fibrosis: A cross-sectional study.
Sahu RK; Patro S; Nayak B; Bardhan D; Panda S; Rajguru JP
Natl J Maxillofac Surg; 2021; 12(1):78-82. PubMed ID: 34188405
[TBL] [Abstract][Full Text] [Related]
37. Letter to Editor: 'Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis'.
Moosavi MS; Keykha E; Fathi Y
J Oral Pathol Med; 2016 Oct; 45(9):721. PubMed ID: 27612179
[No Abstract] [Full Text] [Related]
38. Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease.
Chaturvedi P; Vaishampayan SS; Nair S; Nair D; Agarwal JP; Kane SV; Pawar P; Datta S
Head Neck; 2013 Oct; 35(10):1404-9. PubMed ID: 22972608
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of oral submucous fibrosis among habitual gutkha and areca nut chewers in Moradabad district.
Nigam NK; Aravinda K; Dhillon M; Gupta S; Reddy S; Srinivas Raju M
J Oral Biol Craniofac Res; 2014; 4(1):8-13. PubMed ID: 25737912
[TBL] [Abstract][Full Text] [Related]
40. Salivary malondialdehyde in oral submucous fibrosis - A marker for oxidative damage.
Ganta SR; Chittemsetti S; Sravya T; Guttikonda VR
J Oral Maxillofac Pathol; 2021; 25(1):82-87. PubMed ID: 34349416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
